Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06NHS
|
|||
Former ID |
DIB021091
|
|||
Drug Name |
TROX-1
|
|||
Synonyms |
GTPL7766; ZINC43203633; AJ-108280
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C22H16ClFN6O
|
|||
Canonical SMILES |
CC1(C2=C(C=CC(=C2)C3=CC(=C(C=C3)F)Cl)N(C1=O)C4=NC=NN4)CC5=CN=CN=C5
|
|||
InChI |
1S/C22H16ClFN6O/c1-22(8-13-9-25-11-26-10-13)16-6-14(15-2-4-18(24)17(23)7-15)3-5-19(16)30(20(22)31)21-27-12-28-29-21/h2-7,9-12H,8H2,1H3,(H,27,28,29)
|
|||
InChIKey |
OABSWPUPIHULMQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1141080-15-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated calcium channel alpha Cav2.2 (CACNA1B) | Target Info | Inhibitor (gating inhibitor) | [2] |
KEGG Pathway | MAPK signaling pathway | |||
Calcium signaling pathway | ||||
Synaptic vesicle cycle | ||||
Retrograde endocannabinoid signaling | ||||
Cholinergic synapse | ||||
Serotonergic synapse | ||||
GABAergic synapse | ||||
Dopaminergic synapse | ||||
Taste transduction | ||||
Type II diabetes mellitus | ||||
Morphine addiction | ||||
Nicotine addiction | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||
Ionotropic glutamate receptor pathway | ||||
Metabotropic glutamate receptor group III pathway | ||||
Metabotropic glutamate receptor group II pathway | ||||
Thyrotropin-releasing hormone receptor signaling pathway | ||||
Endogenous cannabinoid signaling | ||||
GABA-B receptor II signaling | ||||
Reactome | Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels | |||
WikiPathways | Calcium Regulation in the Cardiac Cell | |||
Synaptic Vesicle Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7766). | |||
REF 2 | Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker. J Pharmacol Exp Ther. 2010 Aug;334(2):545-55. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.